Therapeutic efficacy of liposomal rifabutin in a Mycobacterium avium model of infection - Wikidata - awgldk - TriplyDB

Therapeutic efficacy of liposomal rifabutin in a Mycobacterium avium model of infection

Therapeutic efficacy of liposomal rifabutin in a Mycobacterium avium model of infection

http://www.wikidata.org/entity/Q28344603

about

Lipid-based nanoformulations of trifluralin analogs in the management of Leishmania infantum infections.Advances in nanotechnology-based carrier systems for targeted delivery of bioactive drug molecules with special emphasis on immunotherapy in drug resistant tuberculosis - a critical review.

P2860

Q40877550-1D696079-F4B1-47D6-BBDD-5F8DE80CBBA9 Q53379436-59542987-DC0F-4469-A246-0DC75D0E9ACF

P2860

Therapeutic efficacy of liposomal rifabutin in a Mycobacterium avium model of infection

http://www.wikidata.org/entity/Q28344603

description

2000 nî lūn-bûn

@nan

2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Therapeutic efficacy of liposomal rifabutin in a Mycobacterium avium model of infection

@ast

Therapeutic efficacy of liposomal rifabutin in a Mycobacterium avium model of infection

@en

Therapeutic efficacy of liposomal rifabutin in a Mycobacterium avium model of infection

@nl

type

label

Therapeutic efficacy of liposomal rifabutin in a Mycobacterium avium model of infection

@ast

Therapeutic efficacy of liposomal rifabutin in a Mycobacterium avium model of infection

@en

Therapeutic efficacy of liposomal rifabutin in a Mycobacterium avium model of infection

@nl

prefLabel

Therapeutic efficacy of liposomal rifabutin in a Mycobacterium avium model of infection

@ast

Therapeutic efficacy of liposomal rifabutin in a Mycobacterium avium model of infection

@en

Therapeutic efficacy of liposomal rifabutin in a Mycobacterium avium model of infection

@nl

P1433

Q28344603-12E108EA-F511-4B0F-8CF8-AC4C4F7AB81C

P1476

Q28344603-DD50CD77-00F2-43D3-88D6-D714E7B13B77

P2093

Q28344603-5CB6ACE2-3BDD-4D8A-9CE9-28142481E013

Q28344603-5DC9CD0A-7718-42F6-B2AF-A0634D84BFFE

Q28344603-A5EFECE4-E76C-4227-B542-DF658CAF225B

P2860

Q28344603-012EBBC2-2135-4D68-8182-4E1442A29FAE

Q28344603-0E53571A-39F9-40E1-AF89-D4AA8C083BA7

Q28344603-1116A576-50D7-4066-9D93-86508D800327

Q28344603-1443A950-1C95-4962-8F8E-B50E2F833C26

Q28344603-248AC519-C2EC-4600-86DF-42A081D4A1F0

Q28344603-25935766-6307-4BEF-9BB9-FD7280FEA958

Q28344603-31C1B556-F2F5-4A9C-B03C-1A8FBFB49DAE

Q28344603-324E8FA9-E545-446E-9A60-1C69588B9935

Q28344603-3E422448-7A19-4B6C-BB63-849765AD6BAC

Q28344603-479256F5-E13E-46DB-83F2-E79CF7686AD6

P304

Q28344603-5FBC1403-9435-4467-A097-22A39E46686C

P31

Q28344603-C132B624-6A9A-4DB2-9A35-9211567CAE69

P356

Q28344603-B7891015-1E6F-4A52-A5C9-640D7EA5475B

P407

Q28344603-BF5DB9A8-1E5D-4B4C-8DC4-F4F2A8BECFE3

P433

Q28344603-4A939F29-7034-4F92-88CC-C277E097C541

P478

Q28344603-D6AEEB69-B24C-44F4-AA25-E9BE585EC2CE

P50

Q28344603-7A27EABB-6AA9-433D-8FB2-D69660440933

Q28344603-7C0E2B8D-778F-4C3B-909A-DFC3BC3BD2EC

Q28344603-9A14F29B-A52A-44CB-B307-79C379359F98

P577

Q28344603-8940FA48-E772-4D82-8882-067A82869581

P698

Q28344603-D2110E7D-BCAB-4EC9-8D1F-93DFDC736B44

P932

Q28344603-58E1B06C-028C-4CC6-AE07-280FA325B139

P356

AAC.44.9.2424-2430.2000

P1433

Antimicrobial Agents and Chemotherapy

P1476

Therapeutic efficacy of liposomal rifabutin in a Mycobacterium avium model of infection

@en

P2093

F Portaels

http://www.w3.org/2001/XMLSchema#string

M T Silva

http://www.w3.org/2001/XMLSchema#string

S Neves

http://www.w3.org/2001/XMLSchema#string

P2860

Disseminated Mycobacterium avium complex infection: clinical identification and epidemiologic trends

Liposome-encapsulated-gentamicin therapy of Mycobacterium avium complex infection in beige mice

Liposome-encapsulated-amikacin therapy of Mycobacterium avium complex infection in beige mice

Enhanced effect of liposome-encapsulated amikacin on Mycobacterium avium-M. intracellulare complex infection in beige mice

Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection

Mycobacterium avium complex infection in patients with the acquired immunodeficiency syndrome. A clinicopathologic study.

Therapy of Mycobacterium avium complex infections in beige mice with streptomycin encapsulated in sterically stabilized liposomes.

Liposome encapsulation of clofazimine reduces toxicity in vitro and in vivo and improves therapeutic efficacy in the beige mouse model of disseminated Mycobacterium avium-M. intracellulare complex infection.

Therapeutic efficacy of liposomal clofazimine against Mycobacterium avium complex in mice depends on size of initial inoculum and duration of infection.

Pharmacokinetics, toxicity, and efficacy of liposomal capreomycin in disseminated Mycobacterium avium beige mouse model

P304

2424-2430

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.44.9.2424-2430.2000

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P50

Maria Manuela Gaspar

Maria Eugénia Meirinhos Cruz

P577

2000-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10952590

http://www.w3.org/2001/XMLSchema#string

P932

90080

http://www.w3.org/2001/XMLSchema#string